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Recombinant proteins expressed in E. coli are frequently purified by immobilized metal affin-
ity chromatography (IMAC). By means of this technique, tagged proteins containing a poly-
histidine sequence can be obtained up to 95% pure in a single step, but some host proteins
also bind with great affinity to metal ions and contaminate the sample. A way to overcome
this problem is to include a second tag that is recognized by a preexistent monoclonal anti-
body (mAb) in the gene encoding the target protein, allowing further purification. With this
strategy, the recombinant protein can be directly used as target in capture ELISA using plates
sensitized with the corresponding mAb. As a proof of concept, in this study we engineered a
Trichinella-derived tag (MTFSVPIS, recognized by mAb US9) into a His-tagged recombinant
Fasciola antigen (rFhLAP) to make a new chimeric recombinant protein (rUS9-FhLAP), and
tested its specificity in capture and indirect ELISAs with sera from sheep and cattle. FhLAP
was selected since it was previously reported to be immunogenic in ruminants and is
expressed in soluble form in E. coli, which anticipates a higher contamination by host proteins
than proteins expressed in inclusion bodies. Our results showed that a large number of sera
from non-infected ruminants (mainly cattle) reacted in indirect ELISA with rUS9-FhLAP after
single-step purification by IMAC, but that this reactivity disappeared testing the same antigen
in capture ELISA with mAb US9. These results demonstrate that the 6XHis and US9 tags
can be combined when double purification of recombinant proteins is required.
Introduction
The detection of serum antibodies induced by parasitic infections using ELISA methods
depends on the availability of enough amounts of specific antigens, either natural or recombi-
nant, to be used in the immunoassays. For this purpose, it would be expected that recombinant
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antigens were more specific than natural ones, but several studies have shown just the contrary
[1–4]. Although this phenomenon has not yet been investigated in detail, some reports pointed
out that the presence of contaminants derived from the expression of His-tagged proteins in E.
coli may explain the poor specificity of such antigens [5]. Optimized E. coli expression [6],
acidic washes [7,8], and washing with low amounts of imidazole [9] are methods commonly
used to prevent the co-purification of proteins on immobilized metal affinity chromatography
(IMAC), thus improving the purity of His-tagged recombinant proteins. Also, disulfide bond
formation between the protein of interest and other proteins, as well as nonspecific hydropho-
bic interactions, can be minimized by inclusion of 2-mercaptoethanol and non-ionic deter-
gents, respectively, in the loading buffer [8]. However, since a relevant fraction of contaminant
E. coli proteins exhibit moderate to strong affinity for metal-chelating resins [9], these methods
do not guarantee complete purity of recombinant proteins and may decrease the yield of the
purified protein.
Another way to overcome the above problems is grafting a second linear epitope tag recog-
nized by a monoclonal antibody (mAb) into the target sequence of interest, thus allowing re-
purification of the protein by affinity chromatography. Currently there are some proprietary
tag-mAb pairs that can be used for affinity-purification and for detection of tagged recombi-
nant proteins [10,11]. However, to the best of our knowledge, none of them were used to
develop sandwich ELISA methods for serodiagnosis of infectious diseases, a strategy that, if
successful, would allow recapturing of the refolded antigen of interest in a single step. To
explore this methodology, in the present study we grafted the linear sequence MTFSVPIS,
located at the amino terminal region of the gp53 antigen from encapsulated species of Trichi-
nella and recognized by the IgG1/κ mAb US9 [12–14], into a His-tagged Fasciola hepatica
recombinant protein (leucine aminopeptidase; FhLAP). FhLAP is a cytoplasmic metalloprotei-
nase isolated from adult flukes [15], which was reported to be able to induce specific antibodies
during infection as well as partial protection against reinfection in immunized sheep [16–18].
Although native [19–21] and recombinant [4,22,23] Fasciola cathepsins (clades L1, L2 and/or
L5) are more adequate as target antigens in ELISA for immunodiagnosis of human and animal
infections, for the proof of concept of the present study, we preferred FhLAP since it can be
expressed soluble in transformed E. coli and, consequently, undesirable host proteins are more
prone to be present. Moreover, since native FhLAP was previously tested as target antigen for
immunodiagnosis of human fascioliasis, this study provides us with the opportunity to evalu-
ate its usefulness to diagnose F. hepatica infections in domestic ruminants (sheep and cattle).
Material and methods
Ethical statement
Blood samples were collected from non-infected and naturally-infected sheep and cattle by
veterinarians from the “Centro de Investigaciones Agrarias de Mabegondo” (INGACAL, A
Coruña, Spain). The animal experimentation of the present study is part of a research INIA
project (RTA2017-00010-C02-01), which was approved by the Ethics Committee of the Con-
sellerı́a do Medio Rural (Xunta de Galicia, Spain). All procedures were carried out in strict
accordance with Spanish and EU legislation (Law 32/2007, R.D. 53/2013 and Council Directive
2010/63/EU).
Collection of biological samples
Sera from non-infected sheep (n = 20) were obtained from animals reared in the Fasciola-free
environment of the “Centro de Investigaciones Agrarias de Mabegondo” (INGACAL-CIAM),
A Coruña (Spain). Sera from Fasciola-infected sheep (n = 18) were obtained from the herd of a
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commercial farm suffering from chronic fascioliasis. All sheep were from an autochthonous
Galician breed (‘‘raza gallega”). Confirmation of the presence or absence of infection was done
by determination of coproantigens in fecal samples using the MM3-COPRO ELISA [24,25]. In
addition, samples of feces from all animals were subjected to sedimentation [26] and flotation
[27] procedures to concentrate the helminth eggs, which were then microscopically examined.
Sera from non-infected cattle (n = 49) and naturally Fasciola-infected cattle (n = 36) were
randomly selected from the collection of sera stored at INGACAL-CIAM. Serum samples
from non-infected cattle were collected from animals belonging to Holstein Friesian and
“rubia galega” strains reared in the Fasciola-free farm from the INGACAL-CIAM. As for non-
infected sheep, fecal samples from these animals tested negative in MM3-COPRO ELISA.
Serum samples from Fasciola-infected cattle were obtained from animals of the strains above,
which were sacrificed at local abattoirs and further classified as infected due to the presence of
flukes in livers (gold standard). Fecal samples from these animals also tested positive by
MM3-COPRO ELISA. As for sheep samples, samples of feces from all animals were examined
for the presence of eggs of F. hepatica and other parasites.
In addition to F. hepatica, nematodes belonging to the families Trichostrongylidae, Moli-
neidae (Nematodirus spp.), Ancylostomatidae, Strongylidae, and Trichuridae (Trichuris spp.)
were frequently identified in both sheep herds. Regarding cattle samples, individual records at
farms revealed that most of them were routinely treated with albendazole during the dry
period and vaccinated against infectious bovine rhinotracheitis and bovine respiratory disease
(bovine respiratory syncytial virus, parainfluenza virus type 3 and Mannheimia haemolytica).
Some were also vaccinated at the end of the gestation period against coronavirus, rotavirus
and E.coli, although individual vaccination records were not available. As expected, most of
the cows had intestinal nematodes from one or more genera of Trichostrongylidae, Trichuri-
dae (Trichuris spp.) and Strongylidae families.
Bacterial and parasite antigens
The Fasciola excretory-secretory antigens (ESAs) used in the MM3-SERO ELISA (see below)
were obtained as previously reported [28,29]. Briefly, live adult flukes were collected from
the bile ducts of naturally infected cows and washed, first in sterile saline solution containing
antibiotics (penicillin/streptomycin) and glucose (2 g/L), at 38˚C, and then in RPMI 1640 cell
culture medium supplemented with 20 mM HEPES, 0.3 g/L L-glutamine, 2 g/L sodium bicar-
bonate and antibiotics, at 38˚C under 5% CO2 in air. The flukes were then transferred to
75-cm2 tissue culture flasks and maintained in culture medium (3 mL/fluke) at 38˚C under 5%
CO2 in air. After 24 h incubation, the medium containing the secreted antigens was removed
and centrifuged at 10,000 g for 20 min at 4˚C in the presence of protease inhibitors (SigmaFast
Protease Inhibitor Tablets, Sigma-Aldrich, Madrid, Spain). The supernatant was then passed
through a 0.45-μm pore filter disk, concentrated in an Amicon 8050 ultrafiltration cell (Ami-
con, Inc., Beverly, MA) equipped with a YM10 membrane (10 kDa molecular weight cut-off),
dialyzed against PBS, sterilized by filtration and, finally, stored at -80˚C until required. The
protein concentration was measured using the Micro BCA Protein Assay Kit (Pierce; Thermo
Fisher Scientific, Barcelona, Spain).
Production and purification of mAbs US9 and MM3
Hybridoma cells secreting mAbs US9 and MM3 were obtained as previously described
[13,24]. The secreting hybridoma cells were grown intraperitoneally in pristan-primed BALB/
c mice, and the anti–Trichinella and F. hepatica IgG1/κ antibodies were purified from the
ascitic fluid by caprylic acid/ammonium sulfate precipitation [30].
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Cloning of the FhLAP gene
Complementary DNA (cDNA) synthesis was carried out with the Marathon cDNA amplifica-
tion kit (Clontech, Palo Alto, CA) employing 1 μg of adult F. hepatica mRNA extracted by Fast
Track mRNA Isolation Kit (Invitrogen, San Diego, CA) and following the protocols described
in Muiño et al. [31]. The FhLAP gene was amplified by Touchdown-PCR using a set of primers
based on the sequence gb|AY644459: FhLAP-Fc: 5'-ATGGCGGCGTTGGCTGTGGGCGTGTC
T-3' FhLAP-Rc: 5'-CTATTTGAATCCCAGTCGTGGTAGTACGTAACGGCTGGCGAAC-3'.
A combination of a DNA polymerase and a hot start enzyme Taq DNA Polymerase (Advan-
tage mix polymerase kit, Takara Bio USA Inc., Mountain View, CA) was used following the
provider’s instructions. The F. hepatica cDNA was used as template at a 1/250 dilution. Then
the amplified FhLAP gene (1562 bp) was cloned into the vector pGEM-T vector (Promega Bio-
tech Ibérica SL, Madrid, Spain) following standard protocols [32]. Positive recombinant plas-
mids were selected by standard PCR with the universal primers D and SP6. Further, the
plasmid FhLAP DNA extracted from the gel (QIAquick Gel Extraction, Qiagen; Qiagen Iberia
SL, Madrid, Spain) was automatically sequenced, using fluorescence-base labeling with ABI
PRISM system (Perkin Elmer, Langen, Germany), to rule out any sequences errors.
Production and subcloning of the US9-FhLAP chimeric gen
A chimera (US9-FhLAP) containing the complete FhLAP gene and the amino acids
(MTFSVPIS) corresponding to the epitope of the mAb US9 [14] was constructed. The chimera
assembly was performed by standard PCR, using standard polymerase (Biotools, Madrid,
Spain) and the primers US9-FhLAP-F: 5'-GGATCC-ATGACATTTTCAGTTCCTATTTCCAT
GGCGGCGTTGG-3'. US9-FhLAP-R: 5'-AAGCTT-CTATTTGAATCCCAGTCGTGG-3'.
Plasmid pQE30-US9-FhLAP DNA (10 LAP1) was used as template at a 1/1,000 dilution to
amplify the chimera. Directional cloning in the pQE expression vector (Qiagen) was per-
formed using the BamH I and Hind III restriction endonucleases (Roche Molecular Systems,
Inc.) and following standard protocols [32]. Positive recombinant plasmids were selected by
standard PCR with the universal primers pQE-forward and pQE-reverse. Further, the plasmid
US9-FhLAP DNA extracted from the gel (QIAquick Gel Extraction, Qiagen) was automatically
sequenced using fluorescence-based labeling with ABI PRISM system (Perkin Elmer, Langen,
Germany) to rule out any sequences errors. Besides the universal pQE forward and reverse
primers, the following four new primers (two designed in the amino and carboxy terminal
regions and two in middle of the LAP sequence) were used in the sequencing procedure:
FhLAP AMINO FWD: 5'-ATGGCGGCGTTGGCTGTG-3', FhLAP CENTRAL REV: 5'-CA
TAAGTGATACCTTTTCCAATCA-3', FhLAP CENTRAL FWD: 5'-GAGCCGCCCAATCCA
ACCGAGG-3’, FhLAP CARBOXY REV: 5'-CTATTTGAATCCCAGTCGTGG-3'. Recombi-
nant pQE30-US9-FhLAP was transformed into XL1 Blue cells (Agilent, Santa Clara, CA),
which were mixed with 20% of sterile glycerol and stored at -80˚C.
Obtaining and purification of rUS9-FhLAP
The M15 [pREP4] E. coli strain (Qiagen) was transformed with 10 ng of recombinant
pQE30-US9-FhLAP DNA. A colony of transformed cells was grown in 1 L of LB medium at
37˚C with shaking (200 rpm/min) until reaching an OD600 of 0.5 and the rUS9-FhLAP protein
expression induced by the addition of 0.5 mM IPTG to the cell culture and further incubation
for 6 h at 22˚C with shaking (120 rpm/min). Then, the cells were harvested by 20 min centrifu-
gation at 5,000 g and stored frozen during 24 h at -30˚C. Afterwards, the pellet was resus-
pended in 50 mL of B-PER Bacterial Protein Extraction Reagent (Thermo Fisher Scientific)
supplemented with lysozyme and DNase I, as indicated by the supplier, pipetted up and down
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until the suspension was homogeneous and incubated with shaking (150 rpm/min) for an
additional 30 min at RT. To separate soluble proteins from the insoluble ones the cell lysate
was centrifuged at 15,000 g for 15 min and the supernatant containing the soluble rUS9-Fh-
LAP was purified by IMAC chromatography with the HIS-Select Nickel Affinity Gel (Sigma-
Aldrich) under non-denaturing conditions.
To carry out the IMAC procedure, the column containing the HIS-Select Nickel Affinity
Gel was pre-equilibrated with PBS and the solution containing soluble rUS9-FhLAP (pre-
diluted 1/4 with PBS containing 10 mM imidazole) was added with the aid of a peristaltic
pump (5 mL/min). Then, the column was washed with 5 volumes of PBS containing 10 mM
imidazole and the protein eluted with PBS containing 250 mM imidazole under UV monitor-
ing. Finally, the protein was concentrated by ultrafiltration in an Amicon Stirred Ultrafiltra-
tion Cell equipped with a Filtron Omega Series membrane (10 kDa nominal molecular weight
limit; Pall Corporation, Port Washington, NY), filtered by 0.22 μm, supplemented with 5%
glycerol and stored at -30˚C until later use in ELISA. Prior to addition of glycerol, the protein
concentration was measured by Micro BCA Protein Assay Kit (Thermo Fisher Scientific).
Additionally, non-transformed M15 cells were grown at 37˚C for 8h without addition of
IPTG, harvested by centrifugation and lysed with B-PER reagent as indicated as above. Then,
the B-PER solution containing the soluble proteins was diluted 4-fold with PBS containing 5
mM imidazole and subjected to IMAC chromatography under the same conditions as above,
except that PBS containing 5 mM imidazole was used for column washes.
SDS-PAGE and Western-blotting (WB) analysis
The soluble protein fraction extracted after induction with IPTG of transformed, and non-
transformed, M15 cells (see above), and the protein fractions purified by IMAC were separated
in 10–20% linear gradient polyacrylamide gels, as previously described [33]. The separated
proteins were stained with BlueSafe (Nzytech, Lisboa, Portugal) or transferred to PVDF mem-
branes (Immobilon-P, Millipore Ibérica SA, Madrid, Spain) in a Trans-Blot SD transfer cell
(Bio-Rad Laboratories, Richmond, CA, USA) and blocked with PBS with 0.05% Tween 20 and
1% dry skimmed milk (PBS-T-SM) for 2 h at RT on an orbital shaker. Membranes were then
incubated with mAb US9 (1/2,000) followed by HRP-conjugated goat anti-mouse IgG anti-
body (Bio-Rad, 1/3,000) after a washing step (three times with PBS-T for 5 min each), or with
HRP-conjugated mouse anti-polyhistidine (Sigma-Aldrich, 1/100,000). Each antibody was
incubated for 1 h at RT on an orbital shaker. Finally, the membranes were washed again, and
the bands were developed using 3,3-diaminobenzidine tetrahydrochloride tablets (Sigma-
Aldrich), following the supplier’s instructions.
ELISA procedures
Capture ELISA with mAb MM3 (MM3-ELISA). The MM3-ELISA was used as reference
method to compare the sensitivity and specificity of this test with the results obtained using
rUS9-FhLAP as target antigen in indirect and capture ELISAs (see below). This method,
which uses the mAb MM3 to capture Fasciola L-cathepsins secreted by adult flukes (L1, L2
and L5 [4,31]), is very similar to the previously described MM3-SERO ELISA [34] with some
modifications. Briefly, polystyrene microtiter plates (Greiner BioOne 96 well 8 X F12 strips,
high binding plates) were coated with purified mAb MM3 (100 μL/well at 5 μg/mL in PBS),
incubated ON at 4˚C, washed three times with PBS and blocked with 200 μL/well of 1.5%
sodium caseinate in PBS for 1 h at RT. Aliquots of 100 μL of F. hepatica ESAs at 1 μg/mL in
PBS or PBS only were added to each well in odd (Ag+) and even (Ag-) plate rows, respectively.
The plates were incubated for 2 h at RT and then washed three times with PBS, before 100 μL
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of each serum sample (from sheep or cattle) diluted 1/100 in PBS-T-SM was added to each Ag
+ and Ag- well in duplicate. The plates were then incubated for 30 min at RT with shaking at
750 rpm, washed five times with PBS-T, and bound IgG antibodies were detected with either
HRP-conjugated mouse anti-sheep/goat IgG monoclonal antibodies (Sigma–Aldrich, 1/30,000
in PBS-T-SM), or HRP-conjugated sheep anti-bovine IgG1 polyclonal antibodies (Bio-Rad, 1/
6,000 in PBS-T-SM). The plates were then washed, as above, and incubated for 20 min at RT
with 100 μL/well of the enzyme substrate OPD (SigmaFast OPD, Sigma-Aldrich). Finally, the
optical density (OD) was measured at 492 nm. The OD values for each sample were calculated
as OD1-OD2, where OD1 is the value for the Ag+ well, and OD2 is the value for the Ag- well.
Two cut-off values for sheep and cattle were considered to maximize specificity. Cut-off 1 was
calculated as the sum of the maximal OD value obtained for negative sera from each species
plus one SD [4] and cut-off 2 was determined by means of Receiver Operating Characteristic
(ROC) analysis for 100% specificity.
Capture ELISA with mAb US9. Polystyrene microtiter plates (Greiner BioOne 96 well 8
X F12 strips, high binding plates) were coated with purified mAb US9 (100 μL/well at 5 μg/mL
in PBS), incubated ON at 4˚C, washed three times with PBS and blocked with 200 μL/well of
1.5% sodium caseinate in PBS for 1 h at RT. Aliquots of 100 μL of a previously calculated opti-
mal concentration of IMAC-purified rUS9-FhLAP (15 μg/mL) in PBS-T-SM, or PBS-T-SM
only, were added to each well in odd (Ag+) and even (Ag-) plate rows, respectively. The plates
were incubated for 30 min at RT with shaking at 750 rpm and then washed five times with
PBS-T, before 100 μL of each serum sample (from sheep or cattle) diluted 1/100 in PBS-T-SM
was added to each Ag+ and Ag- well in duplicate. The plates were then incubated for 30 min at
RT with shaking at 750 rpm, washed five times with PBS-T and specific sheep or bovine IgG
was detected as described above. The OD values for each sample and the cut-off values were
calculated as for the MM3-ELISA.
Indirect ELISA with rUS9-FhLAP. The wells of ELISA plates were coated with 100 μL of
a previously calculated optimal concentration of IMAC-purified rUS9-FhLAP protein (3 μg/
mL) in PBS, incubated for 2 h at 37˚C, washed three times with PBS and blocked with 200 μL/
well of 1.5% sodium caseinate in PBS for 1 h at RT. Aliquots of 100 μL of each serum sample
(from sheep or cattle) diluted 1/100 in PBS-T-SM were added to each well of the plates in
duplicate and incubated for 30 min at RT with shaking at 750 rpm. The plates were then
washed five times with PBS-T, and bound IgG antibodies were detected as described above.
The OD values for each sample and the cut-off values were calculated as for the MM3-ELISA.
Indirect competitive ELISA with rUS9-FhLAP. In order to determine the possible reac-
tivity of sera with the US9 epitope included in the rUS9-LAP chimeric sequence, an indirect
competitive ELISA was developed with the cattle serum samples in parallel with the above
indirect rUS9-FhLAP ELISA. As inhibitor, the synthetic peptide MTFSVPIS (US9-recognizing
epitope) was used. The mAb US9, diluted 1/1,000, was used as a control to calculate the opti-
mal inhibitory concentration of the US9 synthetic peptide, which was tested in the range
0.5 μM to 1 mM. Complete inhibition of US9 binding was achieved at a peptide concentration
of 0.0625 mM; consequently, the previous peptide dilution (0.125 mM) was selected to be used
for inhibition of sera in indirect competitive ELISA. This assay was performed as described
above for indirect rUS9-FhLAP ELISA but using cattle sera prediluted 1/100 in PBS-T-SM
containing 0.125 mM of the US9 peptide and incubated for 30 min at RT before addition to
the ELISA wells.
Indirect ELISA with IMAC-retained M15 proteins. The wells of ELISA plates were
coated with 100 μL of IMAC-retained M15 soluble proteins (4 μg/mL) in PBS, incubated ON
at 4˚C, washed three times with PBS, and blocked with 200 μL/well of 1.5% sodium caseinate
in PBS for 1 h at RT. Aliquots of 100 μL of sera from non-infected cattle diluted 1/100 in
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PBS-T-SM were added to the wells of the plates in duplicate and incubated for 30 min at RT
with shaking at 750 rpm. The plates were then washed five times with PBS-T, and bound IgG
antibodies were detected with HRP-conjugated sheep anti-bovine IgG1 polyclonal antibodies
as described above. The OD values for each sample were calculated by subtracting the non-spe-
cific binding obtained in the absence of cattle serum (OD = 0.042).
LPS immunoassays. The wells of ELISA plates were coated with 100 μL of a PBS solution
containing LPS from E. coli serotype O55:B5 (Sigma-Aldrich) at 10 μg/mL, incubated for 2 h
at 37˚C, washed three times with PBS, and blocked with 200 μL/well of 1.5% sodium caseinate
in PBS for 1 h at RT. Aliquots of 100 μL of each serum sample from non-infected cattle, diluted
1/100 in PBS-T-SM, were added to each well of the plates in duplicate, and incubated for 30
min at RT with shaking at 750 rpm. The plates were then washed five times with PBS-T, and
bound IgG antibodies were detected as described above for MM3-ELISA. Finally, the OD was
measured at 492 nm.
To detect the presence of LPS from M15 cells in the wells of ELISA plates coated with
rUS9-FhLAP, or mAb US9 plus rUS9-FhLAP, the plates were incubated with 100 μL/well of a
goat anti-lipid A LPS polyclonal antibody (ThermoFisher Scientific, Rockford, USA) diluted 1/
100 in PBS-T-SM and incubated for 30 min at RT with shaking at 750 rpm. The plates were
then washed five times with PBS-T, and bound IgG antibodies were detected with HRP-conju-
gated mouse anti-sheep/goat IgG monoclonal antibodies (Sigma–Aldrich, 1/30,000 in
PBS-T-SM). Finally, the OD was measured at 492 nm. Wells of an ELISA plate coated with E.
coli O55:B5 LPS (see above) were used to adjust the adequate dilution of anti-lipid A LPS poly-
clonal antibody, which gave an mean OD value of 0.52 at a 1/100 dilution under these
conditions.
Bioinformatics tools
Theoretical isoelectric points, instability indices, aliphatic indices and grand average of hydro-
pathicity (GRAVY) values were calculated using the ProtParam bioinformatics tool from
Expasy (https://www.expasy.org/resources).
Statistical analysis
The Spearman correlation coefficients (r) were calculated using GraphPad InStat 3.05 (Graph-
Pad Software, Inc., La Jolla, CA) and OriginPro v 7.5 (OriginLab Corporation, Northamptom,
CA) software packages. Differences were considered significant at p<0.05. The ROC curves
were calculated using the MedCalc v. 17.7.2 software (MedCalc Software, Ostend Belgium).
Results
Cloning and expression of the rUS9-FhLAP chimeric protein
The alignment of the amino acid sequence corresponding to the ORF of the FhLAP protein
cloned in this study (gb| MF945962) and the sequence reported by Acosta et al. (unpublished
results; gb| AAV59016.1) is shown in Fig 1. The extra amino terminal region (underlined),
which includes the corresponding 6XHis tag (blue) and the US9 epitope (red), is also dis-
played. Considering the US9 epitope sequence alone, the ProtParam bioinformatics tool indi-
cated that such sequence is hydrophobic in nature, with an aliphatic index of 85 and a GRAVY
value of 1.188 (highly hydrophobic). However, considering the complete amino acid sequence
inserted in the amino terminal region of rUS9-FhLAP, i.e., the first 20 residues in Fig 1 (under-
lined), the aliphatic index decreased to 34.0 and the GRAVY value was -0.735 (moderately
hydrophilic). In addition to the initial residue M, one R and two dipeptides (GS) flanking the
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6XHis and the US9 tags were also introduced in the recombinant protein because of the clon-
ing procedure in the pQE30 vector excised with BamH I and Hind III restriction enzymes.
Comparing the cDNA sequences gb| MF945962 and gb| AAV59016, we observed that both
have the same extension (1569 bp) a very high identity (99.99%) with only 8 nucleotide
changes (C31T, C78A, G93A, T1090C, C1210G, C1251T, C1337T, A1489G). Moreover, the translation
of the nucleotide sequence gb| MF945962 revealed the existence of only 4 amino acid changes
located in the carboxy terminal region (C364R; P404A; T446I and T497A) with respect to the
parental sequence gb| AAV59016 (see Fig 1).
As deals with the expression of rUS9-FhLAP, the WB analysis shown in Fig 2A revealed
that the protein is correctly expressed in E. coli, appearing as a major band with an approxi-
mate Mr of 60 kDa (theorethical MW = 58,665.25 Da). Also, several minor bands of different
MW (lane 3) can be observed, which probably correspond to truncated proteins and/or E. coli
contaminants copurified during the IMAC procedure. The presence of rUS9-FhLAP truncates
could be confirmed in WB revealing the proteins with mAb US9 (lane 4) and a mAb recogniz-
ing the poly-His tag (Fig 2A, lane 5). Moreover, the excellent recognition of both the whole
protein and rUS9-FhLAP truncates by mAb US9 indicated that the positioning of the US9 epi-
tope between the poly-His tag and the FhLAP sequence is adequate for the objective of the
study. In addition, we investigated if the rUS9-FhLAP is also correctly recognized in ELISA by
a serum from a Fasciola-infected sheep. The data in Fig 2B and 2C showed that the sheep
serum reacted with the recombinant antigen in a dose-dependent manner and that the ELISA
signal reached a plateau at antigen concentrations over 10 μg/mL for US9-ELISA and over
3 μg/mL for indirect ELISA.
Recognition of rUS9-FhLAP by sera from infected and non-infected
ruminants
As indicated above, a single-step affinity-purification of soluble recombinant antigens pro-
duced in E. coli by IMAC may involve the presence of variable amounts of contaminant pro-
teins from the host which may have negative consequences on the specificity of indirect
Fig 1. Alignment of gb| AAV59016 (parental) and gb| MF945962 (this study) recombinant FhLAPs from F. hepatica. Showed are the differences in the
amino acid sequences between both proteins as well as the amino terminal region containing the two inserted tags (6XHis, blue) and US9 (MTFSVPIS,
red), and the extra residues (including two GS dipeptides) introduced during the cloning procedure.
https://doi.org/10.1371/journal.pone.0211035.g001
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ELISAs. To investigate whether this inconvenient can be avoided by in-plate recapturing of
the rUS9-FhLAP antigen by mAb US9, we compared the recognition of such antigen in indi-
rect and capture US9-ELISA by sera from non-infected or naturally F. hepatica-infected sheep
and cattle. Each serum was tested simultaneously in indirect ELISA using rUS9-FhLAP cou-
pled to the wells of ELISA plates, and in two capture ELISAs, US9-ELISA and MM3-ELISA
(reference method). Also, since the study was designed to investigate the effect of contaminat-
ing proteins present in antigen preparations affecting the specificity of the assays, two cut-off
values (cut-off 1 and cut-off 2; see Material and Methods section) that guarantee maximum
specificity were used.
Considering sera from sheep (Fig 3) and cut-off 1, 17/18 (94.4%) true positive samples were
obtained by indirect ELISA, while 100% of samples from infected sheep tested positive using
the less-restrictive cut-off 2 value, i.e., calculated by ROC analysis. The same percentages were
also obtained analyzing the sera by US9-ELISA, but the serum testing negative using the
respective cut-off 1 in indirect ELISA and in US9-ELISA was not the same.
Fig 2. Analysis of the expression of the chimeric recombinant protein rUS9-FhLAP in E. coli and optimization of its use in ELISA. (A)
SDS-PAGE and WB analysis of rUS9-FhLAP expression. Lane 1: MW markers. Lane 2: Coomasie blue staining of the soluble protein fraction
obtained after induction with 0.5 mM IPTG. Lane 3: Coomasie blue staining of rUS9-FhLAP after purification by IMAC. Lane 4: WB analysis
of rUS9-FhLAP revealed with mAb US9 as primary antibody. Lane 5: WB analysis of rUS9-FhLAP revealed with HRP-conjugated anti-
polyhistidine. (B) ELISA OD values obtained testing different concentrations of rUS9-FhLAP (range: 0.7–22 μg/mL) as target antigen in
capture ELISA with mAb US9. (C) ELISA OD values obtained testing different concentrations of rUS9-FhLAP (range: 0.3–11 μg/mL) as target
antigen in indirect ELISA. The analysis was carried out with a serum from a Fasciola-infected sheep as primary antibody.
https://doi.org/10.1371/journal.pone.0211035.g002
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Although most sheep sera were correctly classified using either indirect ELISA or capture
US9-ELISA, if we consider the differences obtained between the OD values for each positive
sera and the corresponding cut-off values, the best results were obtained, as expected, with
MM3-ELISA, followed by US9-ELISA. In this sense, it should be noted that, for both cut-offs,
these differences were greater than 0.9 for our reference method (MM3-ELISA), while only 4/
18 (22.2%) of sera reached these values with the other two ELISA methods. These data strongly
suggest that FhLAP is recognized during infection of sheep by F. hepatica but that this protease
provokes a lesser antigenic stimulus than L-cathepsins, probably due to two facts: i) unlike
FhLAP (cytoplasmatic), Fasciola L-cathepsins are the most abundant secreted proteins, thus
being permanently in contact with host immune cells, and ii) during its biological cycle, Fas-
ciola produces different L-cathepsins [35] that have high sequence identity and thus may recip-
rocally boost the production of antibodies.
Fig 3. ELISA OD values obtained testing sera from Fasciola–free (open circles) and Fasciola–infected (closed
circles) sheep. Each point in the figure represents the mean OD value (two replicates) obtained for one individual
serum sample. IND = sera tested in indirect ELISA with rUS9-FhLAP antigen as target. US9 = sera tested in capture
ELISA with mAb US9 coupled to ELISA plates and rUS9-FhLAP as target antigen. MM3 = sera tested in capture
ELISA with mAb MM3 (MM3-ELISA; reference test). Horizontal lines represent the cut-off values (red dashed line:
cut-off 1; blue line: cut-off 2). Cut-off 1 and cut-off 2 values for each ELISA were as follows: OD = 0.205 and 0.16
(IND); OD = 0.114 and 0.089 (US9); OD = 0.009 and 0.007 (MM3).
https://doi.org/10.1371/journal.pone.0211035.g003
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As for sheep, all sera from infected and non-infected cattle were correctly classified using
the MM3-ELISA regardless of the two cut-off values investigated (Fig 4). However, the data in
Fig 4 also revealed that the antigens present in the rUS9-FhLAP preparation are strongly rec-
ognized by a large number of non-infected cattle sera in indirect ELISA. In this sense, we
observed that 33/49 (67.3%) of sera from non-infected cattle produced OD values�0.2 (range
OD = 0.069–0.963) after subtracting the corresponding non-specific binding value of the plate
(OD = 0.06; without serum). As expected, the high reactivity of these sera limited the number
of infected cattle sera testing positive in indirect ELISA, as only 10/36 (27.8%) and 13/36
(36.1%) samples were classified as positive using cut-off 1 and cut-off 2, respectively.
Fig 4. ELISA OD values obtained testing sera from Fasciola–free (open circles) and Fasciola–infected (closed
circles) cattle. Each point in the figure represents the mean OD value (two replicates) obtained for one individual
serum sample. IND = sera tested in indirect ELISA with rUS9-FhLAP antigen as target. US9 = sera tested in capture
ELISA with mAb US9 coupled to ELISA plates and rUS9-FhLAP as target antigen. MM3 = sera tested in capture
ELISA with mAb MM3 (MM3-ELISA; reference test) and Fasciola ESAs as target antigen. Horizontal lines represent
the cut-off values (red dashed line: cut-off 1; blue line: cut-off 2). Cut-off 1 and cut-off 2 values for each ELISA were as
follows: OD = 1.174 and 0.963 (IND); OD = 0.111 and 0.084 (US9); OD = 0.075 and 0.059 (MM3).
https://doi.org/10.1371/journal.pone.0211035.g004
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Unlike in the indirect ELISA, capture of the rUS9-FhLAP antigen by mAb US9 drastically
decreased the OD values obtained with non-infected cattle sera. As can be observed in Fig 4, as
for the MM3-ELISA, the US9-ELISA provided OD values below 0.1 (range 0.0–0.084). However,
the results in Fig 4 also demonstrated that, contrary to L-cathepsins, only part of the infected cattle
produced specific antibodies to FhLAP. Specifically, 18/36 (50%) and 20/36 (55.5%) of infected
cattle sera tested positive by US9-FhLAP ELISA using cut-off 1 and cut-off 2, respectively. Never-
theless, these results were better than those obtained by indirect ELISA (see above).
Although indirect ELISA and capture US9-ELISA immunoassays use the same rFhLAP
antigen, given that they are different in design, a doubt arises concerning the concordance
between classification of positive and negative sera by both methods. To clarify this aspect, we
performed a linear regression analysis between the OD values obtained for non-infected or
Fasciola-infected cattle by both methods. The results in Fig 5 showed that OD values obtained
for non-infected (Fig 5A) and infected (Fig 5B) cattle sera by both methods have very signifi-
cant correlation (P<0.001). However, as indicated by the relatively low R2 values (0.20 and
0.48 for non-infected and infected cattle sera, respectively), particularly for non-infected cattle
sera, a considerable amount of sera produced discordant OD values comparing both ELISA
methods.
In our US9-ELISA, the MTFSVPIS epitope is blocked by the paratope of mAb US9, thus
avoiding its recognition by sera from infected or non-infected animals. However, since this
epitope is freely available when the rUS9-FhLAP antigen is used in indirect ELISA, it could
hypothetically be recognized by cross-reactive antibodies present in sera from infected or non-
infected animals. To discard this possibility, in parallel with the indirect ELISA performed
with the rUS9-FhLAP antigen (see above), we carried out an inhibition ELISA using a syn-
thetic peptide derived from the gp53 Trichinella protein containing the MTFSVPIS sequence
recognized by mAb US9. As expected, the incubation of cattle sera with the peptide did not
change the reactivity of non-infected (Fig 6A) and infected cattle sera (Fig 6B), as was deduced
from the excellent correlation coefficients between OD values of non-inhibited and inhibited
sera (R2 = 0.965 and R2 = 0.917 for non-infected and infected cattle sera, respectively).
In an attempt to identify probable target(s) of cross-reactivity showed by cattle sera, we first
investigated whether this could be due to soluble M15 E. coli proteins that could bind to the
chromatographic column and co-elute during IMAC purification of rUS9-FhLAP. To this
end, the protein profiles of soluble M15 proteins, before and after IMAC-purification, were
firstly revealed by SDS-PAGE and protein staining with BlueSafe (Fig 7A). Then, the eluted
protein fraction was used as target antigen in indirect ELISA to investigate whether it is recog-
nized by sera from non-infected cattle (Fig 7B). The results in Fig 7 clearly showed that: i) a
broad MW range (10–200 kDa) of soluble proteins from non-transformed M15 E. coli bond to
the IMAC column (Fig 7A), ii) these proteins are recognized in indirect ELISA by sera from
non-infected cattle (mean OD = 0.17±0.08SD; OD range: 0.07–0.47), and iii) the reactivity
observed in indirect ELISA testing sera from non-infected cattle (n = 35) significantly corre-
lated (R2 = 0.42; p<0.0001) with that obtained using IMAC-purified rUS9-FhLAP (Fig 7B).
These data, together with the fact that the IMAC-purified M15 protein fraction was able to
inhibit 50–70% of the reactivity of selected sera from non-infected cattle in an indirect ELISA
with rUS9-FhLAP (not showed), clearly indicates that native E. coli proteins bind and co-elute
with recombinant proteins during IMAC purification, and thus constitute a relevant source of
non-specific binding by natural antibodies present in sera from cattle. Moreover, since such
reactivity was not observed when testing the same sera in WB (not showed), it seems that the
target of cattle antibodies are mainly conformational epitopes.
Another possible target for cross-reactive natural antibodies in cattle is LPS [36]. To investi-
gate whether a putative contamination by M15 LPS of rUS9-FhLAP coupled to ELISA plates
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might be targeted by serum antibodies from non-infected cattle, we checked for the presence
of lipid A in the wells of ELISA plates using polyclonal anti-lipid A antibodies. In addition, we
investigated a possible correlation between OD values obtained with sera from non-infected
cattle against rUS9-FhLAP and against E. coli O55:B5 LPS, both in indirect ELISA. As deals
with the presence of lipid A, the anti-lipid A polyclonal antibodies produced low OD values in
wells of ELISA plates coated with rUS9-FhLAP (OD = 0.12) and no signal in the wells coated
with mAb US9 plus rUS9-FhLAP. Moreover, the results in Fig 8 showed no correlation
Fig 5. Least squares linear regression analysis obtained comparing non-infected (A) and Fasciola-infected (B)
cattle sera OD values obtained in indirect ELISA and US9-ELISA. Each point represents the paired OD values
obtained for each serum by both methods. Blue lines represent the 95% upper and lower confidence levels.
https://doi.org/10.1371/journal.pone.0211035.g005
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Fig 6. Least squares linear regression analysis comparing non-inhibited and inhibited (MTFSVPIS peptide) sera
from non-infected cattle (A) or sera from F. hepatica naturally-infected cattle (B). Each point represents the paired
OD values obtained for each serum in indirect ELISA using rUS9-FhLAP as target antigen. Blue lines represent the
95% upper and lower confidence levels.
https://doi.org/10.1371/journal.pone.0211035.g006
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(p = 0.62) between OD values obtained for non-infected cattle sera tested against rUS9-FhLAP
and LPS, both in indirect ELISA. These data suggests that, in our experimental conditions,
contamination by LPS is not a relevant target for the cross-reactivity observed testing sera
from cattle.
Discussion
Epitope tagging is a genetic engineering technique in which a protein encoded by a cloned
gene is fused to an epitope recognized by a known antibody [37,38]. This strategy allows rapid
affinity-purification of recombinant proteins, but it can also be used for protein detection in
WB, flow cytometry and ELISA [39]. Typically, epitope tags (commonly, 5–16 residues in
length) are selected among linear sequences [10,40] and have a negative GRAVY index (i.e.,
hydrophilic) assuming that hydrophilic tags are exposed at the surface and thus are more
accessible to antibodies. Also, in most studies tags have been placed at the amino or carboxy
terminal regions in the belief that the loss of function will be minimal, although this is not a
general rule applicable to any protein (reviewed in [37]).
In our study, we engineered a F. hepatica recombinant FhLAP by incorporating two affinity
tags in tandem (6XHis and MTFSVPIS) at its amino terminal region aimed to improve its
purification free of contaminants by mAb US9 after a first purification by IMAC. While the
classical 6XHis is the most commonly used tag for single-step purification of recombinant pro-
teins, allowing purities of up to 95% with 90% recovery of the tagged protein [8], the remaining
contaminants may be of great importance when these antigens are used as target in
Fig 7. Analysis of soluble E. coli proteins binding to Nickel Affinity Gel columns. (A) SDS-PAGE analysis of M15 E. coli soluble proteins
present in the starting sample (lane 1), in the non-retained fraction (lane 2), and in the eluted fraction (lane 3, concentrated). The relative
mobility of MW standards is shown on the left. (B) Least squares linear regression analysis comparing OD values obtained in indirect ELISA for
sera from non-infected cattle (n = 35) using as target IMAC-purified proteins from non-transformed (M15 response; X-axis) or transformed
(rUS9-FhLAP response; Y-axis) M15 E. coli cells. Each point represents the paired OD values obtained for each serum in the indirect ELISAs.
Blue lines represent the 95% upper and lower confidence levels.
https://doi.org/10.1371/journal.pone.0211035.g007
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immunodiagnosis or in any other situation where a homogeneous product is required. The
advantage of using a dual tag could be evidenced in our study, in which the rUS9-FhLAP puri-
fied in a single step by IMAC showed strong reactivity in indirect ELISA with many sera from
non-infected ruminants (mainly from cattle), but disappeared when these antigens were re-
purified by mAb US9 in capture ELISA. Typical metal-binding contaminants during IMAC
purifications include non-protein components (e.g., phospholipids, nucleic acids and LPS),
but also host cell proteins like outer membrane proteins, stress-responsive proteins (folding
machinery) and ribosomal subunit proteins [41], some of which require more than 80 mM
imidazole for elution [9].
Although the molecular identification of E. coli proteins recognized by sera from sheep and
cattle goes beyond the objectives of the present study, the results of the SDS-PAGE showing the
presence of bands that were not recognized by US9 and anti-His antibodies in WB (Fig 2A),
revealed the presence of contaminant E. coli proteins in the IMAC-purified rUS9-FhLAP. Like-
wise, a great diversity of E. coli proteins with affinity for Ni(II) ions was also observed among
soluble proteins obtained from non-transformed M15 cells (Fig 7A) using PBS plus 5mM imid-
azole as loading and washing buffer. It is also noticeable that false positive results using IMAC-
purified recombinant proteins is not limited to the rUS9-FhLAP antigen of present study, as
similar observations were also reported using the more antigenic Fasciola recombinant cathep-
sins L as target in ELISA after expression in Pichia pastoris and further purification by IMAC
[2]. Moreover, recent studies in our laboratory showed that the number of false positives was
less relevant when the antigens (procathepsins L) were expressed in E. coli as inclusion bodies,
as these aggregates are first washed by centrifugation and most of contaminant host soluble pro-
teins are eliminated prior to denaturation and IMAC affinity-purification [4].
In addition to proteins, LPS was also recognized as a frequent contaminant during IMAC puri-
fication of recombinant protein expressed in E. coli [42]. Although the E. coli M15 cells used in
Fig 8. Least squares linear regression analysis between OD values obtained in indirect ELISA testing sera from
non-infected cattle in response to rUS9-FhLAP (rUS9-FhLAP response; X-axis) and LPS from E. coli serotype
O55:B5 (LPS response; Y-axis). Each point represents the paired OD values obtained for each serum. Blue lines
represent the 95% upper and lower confidence levels.
https://doi.org/10.1371/journal.pone.0211035.g008
Dual tagging of a recombinant Fasciola antigen
PLOS ONE | https://doi.org/10.1371/journal.pone.0211035 February 1, 2019 16 / 20
this study derive from a K12 E. coli strain (https://www.qiagen.com/fr/resources/resourcedetail?
id=abc8b958-d415-4b91-88a1-e5f90d0a1884&lang=en), which lacks the highly antigenic O anti-
gen part of LPS [43], it still retains LPS components, including the lipid A [44], which is poten-
tially antigenic. As in previous studies [36], our data in Fig 8 showed that sera from cattle free of F.
hepatica present relevant levels of anti-LPS (E. coli serotype O55:B5) antibodies. However, the
absence of correlation between such antibody response and that obtained against rUS9-FhLAP
excludes E. coli lipid A as a source of cross-reactivity in our study.
Regarding the physicochemical characteristics of the MTFSVPIS sequence recognized by
mAb US9, it is important to note that, unlike most of previously reported epitope tags [10], it
has intrinsic positive GRAVY (1.188), which denotes its hydrophobic nature and thus would
advise against its use to tag some recombinant proteins. Nevertheless, it should be underlined
that its insertion into the rFhLAP sequence was performed in tandem after the 6XHis tag and
that 5 additional residues were also incorporated into the amino terminal region due to the
cloning procedure. Consequently, twenty extra residues were incorporated into the amino
region of the rFhLAP sequence (1MRGSHHHHHHGSMTFSVPIS20) with a GRAVY = -0.735,
which is in the range of many other epitope tags [10]. It is also noticeable that the US9 epitope
in the chimeric rUS9-FhLAP has a similar position as in the parental mature sequence of gp53
from T. spiralis (1STDNENVAMKEMTFSVPIS19, GRAVY = -0.289; gb|CAD86781.1) and T.
britovi (1STDNENAAMKEMTFSVPIS19, GRAVY = -0.416; gb|CAD86782.1) [13], which
anticipated the good recognition of rUS9-FhLAP by mAb US9. Moreover, the presence of GS
dipeptides before the 6XHis and the US9 epitope probably also facilitates the recognition by
mAb US9, as “GS” linkers are commonly used as flexible linkers to engineer recombinant
fusion proteins [45,46] and to link epitopes within chimeric multiepitope recombinant anti-
gens [47,48]. Finally, it should also be considered that, although the MTFSVPIS sequence
belongs to a nematode protein, its recognition by sera from infected animals in capture ELISA
is not possible since such epitope is not available after binding to the capture antibody (US9).
By testing sera from humans infected with F. hepatica, Marcilla et al. [17] reported that a F.
hepatica native FhLAP may have potential interest in serodiagnosis of human fasciolosis. How-
ever, compared with cathepsins L (MM3-ELISA) our results clearly demonstrated that, at least
in ruminants, the responses to this antigen are discrete and, consequently, cannot be recom-
mended for developing immunodiagnostic tests.
In summary, and as a proof of concept, in this study we demonstrated for the first time that
the introduction of a hydrophobic epitope tag recognized by a mAb into a recombinant anti-
gen from Fasciola can be used for in-plate recapturing of the antigen allowing the design of
new and specific capture ELISAs. This strategy may be advantageous over indirect ELISAs by
at least two reasons: i) unlike in indirect ELISA, all antigen molecules remain oriented in the
space by action of the capture mAb, and ii) an individual control, i.e., a well containing mAb
molecules and the blocking protein, can be used for each serum, thus improving detection of
individuals having antibodies reacting with either the capture mAb or the proteins used to
block the ELISA plates [34]. Further studies are being carried out in our laboratory to investi-
gate if the same strategy can be performed with other Fasciola antigens, such as whole or
selected fragments of cathepsins L, to develop robust immunodiagnostic tests without the
necessity of obtaining live parasites in abattoirs.
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Data curation: Ricardo A. Orbegozo-Medina, Florencio M. Ubeira.
Formal analysis: Victoria Martı́nez-Sernández, Marta González-Warleta, Fernanda Romarı́s,
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Teresa Gárate, Florencio M. Ubeira.
Supervision: Victoria Martı́nez-Sernández, Fernanda Romarı́s, Esperanza Paniagua, Florencio
M. Ubeira.
Validation: Marı́a J. Perteguer, Marta González-Warleta, Florencio M. Ubeira.
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